home.aspx

 
.

ACCELERATING APPROVAL FOR CELL AND GENE THERAPIES

February 27, 2020 | (12:00pm)
USA (United States of America)
SHARESHARESHARE
After decades of slow and steady progress, cell and gene therapies are experiencing important breakthroughs, demonstrating potential to slow disease progression, improve outcomes, and in some cases, potentially cure an array of illnesses. However, navigating complex clinical and regulatory hurdles for these new and cutting-edge therapies is presenting new challenges for developers, particularly for those using accelerated approval pathways. Join experts from Cardinal Health Regulatory Sciences as we explore critical factors to help reduce your risk of failure and increase speed to market. Topics covered, include: